Based on phase 3 trial data, the FDA accepted an sBLA for nivolumab plus AVD for untreated stage III or IV classical Hodgkin lymphoma.

Retatrutide treatment resulted in significant improvements in WOMAC pain scores and body weight compared with placebo in the TRIUMPH-4 trial.

GLP-1 RAs probably have little or no effect on risk for thyroid cancer, pancreatic cancer, breast cancer, or kidney cancer.

Congenital HI is a rare genetic condition that results in persistent hypoglycemia due to the overproduction of insulin. Ersodetug, a fully human monoclonal antibody, binds allosterically to insulin ...

Single inhaled treatment produced significant reductions in symptoms within 24 hours, but effects were not sustained at one week.

While the CDC report is delayed, non-government researchers are tracking trends in real time. A December 9 report from #WeCount, sponsored by the Society of Family Planning, found that abortions in ...

Minimal residual disease is “a credible intermediate endpoint” for some patients with newly diagnosed acute myeloid leukemia, researchers report.

Pegcetacoplan yields significantly greater change in proteinuria than placebo in C3 glomerulopathy or primary immune-complex MPGN.

The homeopathic nasal spray is used to temporarily relieve nasal symptoms associated with cold and flu, including congestion and rhinorrhea. The recalled product, which has a lot number of 224268 and ...

HealthDay News — A widely used blood pressure medication is being pulled from shelves after testing suggested some batches may contain traces of other drugs. Glenmark Pharmaceuticals has recalled ...

Concurrent acalabrutinib, bendamustine, and rituximab in the first-line setting improved outcomes for patients with mantle cell lymphoma (MCL) relative to sequential treatment without acalabrutinib.

Findings seen for older adults experiencing gabapentinoid (gabapentin and pregabalin)-edema-loop diuretic prescribing cascade ...